𝔖 Bobbio Scriptorium

✦ LIBER ✦

Adding cisplatin to gemcitabine improved response and progression-free survival for people with locally advanced or metastatic pancreatic cancer

✍ Scribed by Carlo Riccardo Rossi

Book ID: 114483873
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 86 KB
Volume: 3
Category: Article
ISSN: 1363-4054
DOI: 10.1054/ebon.2002.0029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adding irinotecan to first-line gemcitab

Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer: Abstracted from: Rocha Lima CM, Green MR, Rotche R et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumour response rate. J Clin Oncol 2004;22:3776–83.

✍ Desmond Yip; David Goldstein 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Similar response rates and superior earl

Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma

✍ John Kuruvilla; Tracy Nagy; Melania Pintilie; Richard Tsang; Armand Keating; Mic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB